Interaction with GLP-1 receptor-expressing neurons here produces further activation of important brain nuclei, including the paraventricular and the arcuate nucleus, the nucleus of the solitary tract and the nucleus ambiguous, the bed nucleus of stria terminalis, the central nucleus of the amygdala and the parabrachial nucleus [10]
They suggested that metabolic changes resulting from rapid weight loss, rather than direct damage to hair follicles by GLP-1 treatments, are the most likely cause of the increased hair loss risk
This indicates that while DSIP may have a tendency to reduce infarct size, the effect was not robust enough to be considered statistically significant under the experimental conditions
[DOI] [PMC free article] [PubMed] [Google Scholar] 88.Nicholls S.J., Bhatt D.L., Buse J.B., Del Prato S., Kahn S.E., Lincoff A.M., McGuire D.K., Nauck M.A., Nissen S.E., Sattar N., et al
Results should guide a conversation with your provider
ROSE-010, a GLP-1 analog, displayed a therapeutic potential for abdominal pain in the clinic